Marilyn K. Glassberg

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine · 2014 · 3.9K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Paul W. Noble, Carlo Albera, Williamson Z. Bradford et al. · The Lancet · 2011 · 2.1K citations

Medicine, Clinical Sciences, Pharmacotherapy +8

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 559 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial

Giacomo Lanzoni, Elina Linetsky, Diego Correa et al. · Stem Cells Translational Medicine · 2021 · 433 citations · Full text

Medicine, Immunology, Internal Medicine +17

Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation

Elena A. Goncharova, Dmitry A. Goncharov, Andrew Eszterhas et al. · Journal of Biological Chemistry · 2002 · 430 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17